Influence of Craniosacral Therapy on Anxiety, Depression and Quality of Life in Patients with Fibromyalgia

Table 3

Differences between study groups in Pittsburgh sleep quality index score at baseline and after therapy.

	Baseline (n)						P	25 weeks (n)						P
	IG			PG			Pre-T	IG			PG			1(a)-PT
PSQI	NP	MP	SP	NP	MP	SP		NP	MP	SP	NP	MP	SP
PSQ	0	12	31	2	13	26	.064	0	10	33	5	18	18	.043*
SL	2	6	35	2	7	32	.948	0	22	21	1	12	28	.064
SD	1	12	30	2	5	34	.059	0	19	24	0	10	31	.042*
HSE	1	15	27	0	10	31	.255	0	20	23	0	13	28	.065
SDI	0	17	26	3	14	24	.191	0	27	16	4	10	27	.040*
DD	0	34	9	0	31	10	.592	3	35	5	0	29	12	.065

Values are shown as n = number of patients with no problems, moderate problems, severe problems. PSQI, Pittsburgh sleep quality index; IG, intervention group; PG, placebo group; Pre-T, pre-therapeutic; 1(a) PT, post-therapy (after 25 weeks of treatment); PSQ, Pittsburgh subjective quality; SL, sleep latency; SD, sleep duration; HSE, habitual sleep efficiency; SDI, sleep disturbance; DD, daily dysfunction; NP, no problems; MP, moderate problems; SP, severe problems. *P = .05 (95% CI).